Search

Author/Creator Dai, Li-Li

1. Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study. Issue 3 (September 2022)

Authors:
Su, Bin; Yao, Cheng; Zhao, Qing-Xia; Cai, Wei-Ping; Wang, Min; Lu, Hong-Zhou; Mu, Ting-Ting; Chen, Yuan-Yuan; Liu, Li; Wang, Hui; He, Yun; Zheng, Yu-Huang; Li, Ling-Hua; Chen, Jin-Feng; Yu, Jian-Hua; Zhu, Biao; Zhao, Min; Sun, Yong-Tao; Lun, Wen-Hui; Zhang, Yi-Hang
Journal:
Journal of infection
Issue:
Volume 85:Issue 3(2022)
Page Start:
334
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Prevalence and Management Recommendations for Disease-Related Malnutrition in Chronic Kidney Disease Patients with and without Diabetes. (25th August 2022)

Authors:
Dai, Li-Li; Li, Wei-Li; Zheng, Ding-Feng; Wang, Wei-Hong; Xie, Hao-Fen; Ma, Jian-Wei
Other Names:
Catalano Antonino Academic Editor.
Journal:
International journal of endocrinology
Issue:
Volume 2022(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search